138 related articles for article (PubMed ID: 2019266)
1. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.
Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood BD
Endocrinology; 1990 Aug; 127(2):588-94. PubMed ID: 2115429
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells.
Mayur N; Lewis S; Catherwood BD; Nanes MS
J Bone Miner Res; 1993 Aug; 8(8):997-1003. PubMed ID: 8213262
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and glucocorticoids enhance the effect of 1,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid protein synthesis by rat osteosarcoma cells.
Nishimoto SK; Salka C; Nimni ME
J Bone Miner Res; 1987 Dec; 2(6):571-7. PubMed ID: 3484302
[TBL] [Abstract][Full Text] [Related]
5. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
Theofan G; Price PA
Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
[TBL] [Abstract][Full Text] [Related]
6. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
[TBL] [Abstract][Full Text] [Related]
7. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.
Fraser JD; Price PA
Calcif Tissue Int; 1990 Apr; 46(4):270-9. PubMed ID: 2108798
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
9. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines.
Fraser JD; Otawara Y; Price PA
J Biol Chem; 1988 Jan; 263(2):911-6. PubMed ID: 3257212
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha.
Gilbert L; He X; Farmer P; Boden S; Kozlowski M; Rubin J; Nanes MS
Endocrinology; 2000 Nov; 141(11):3956-64. PubMed ID: 11089525
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of tumor necrosis factor-alpha and interferon-gamma on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8).
Nanes MS; McKoy WM; Marx SJ
Endocrinology; 1989 Jan; 124(1):339-45. PubMed ID: 2491807
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Spiess YH; Price PA; Deftos JL; Manolagas SC
Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter.
Li YP; Stashenko P
J Immunol; 1992 Feb; 148(3):788-94. PubMed ID: 1309841
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells.
Price PA; Baukol SA
J Biol Chem; 1980 Dec; 255(24):11660-3. PubMed ID: 6969260
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures.
Centrella M; McCarthy TL; Canalis E
Endocrinology; 1988 Sep; 123(3):1442-8. PubMed ID: 3402390
[TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor beta 1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells.
Pirskanen A; Jääskeläinen T; Mäenpää PH
J Bone Miner Res; 1994 Oct; 9(10):1635-42. PubMed ID: 7817811
[TBL] [Abstract][Full Text] [Related]
18. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
Pan LC; Price PA
J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
[TBL] [Abstract][Full Text] [Related]
19. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
[TBL] [Abstract][Full Text] [Related]
20. 1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8.
Harrison JR; Petersen DN; Lichtler AC; Mador AT; Rowe DW; Kream BE
Endocrinology; 1989 Jul; 125(1):327-33. PubMed ID: 2737151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
